[HTML][HTML] Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC Chattipakorn, S Thummasorn, J Sanit… - Journal of geriatric …, 2014 - ncbi.nlm.nih.gov
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
S Cchattipakorn, S Thummasorn, J Sanit… - Journal of Geriatric …, 2014 - wprim.whocc.org.cn
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC CHATTIPAKORN… - Journal of Geriatric …, 2014 - pesquisa.bvsalud.org
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC Chattipakorn, S Thummasorn, J Sanit… - Journal of Geriatric …, 2014 - jgc301.com
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC Chattipakorn, S Thummasorn… - Journal of geriatric …, 2014 - pubmed.ncbi.nlm.nih.gov
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
[PDF][PDF] Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC Chattipakorn, S Thummasorn, J Sanit… - Journal of Geriatric …, 2014 - Citeseer
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC Chattipakorn, S Thummasorn, J Sanit… - 2014 - cmuir.cmu.ac.th
Background: Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
[PDF][PDF] Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
SC Chattipakorn, S Thummasorn… - Journal of Geriatric …, 2014 - pdfs.semanticscholar.org
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart.
SC Chattipakorn, S Thummasorn, J Sanit… - Journal of Geriatric …, 2014 - europepmc.org
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart.
SC Chattipakorn, S Thummasorn, J Sanit… - Journal of Geriatric …, 2014 - europepmc.org
Background Cilostazol is a type 3 phosphodiesterase inhibitor which has been previously
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …
demonstrated to prevent the occurrence of tachyarrhythmia and improve defibrillation …